论文部分内容阅读
心力衰竭患者经转换酶抑制剂卡托普利和 enalapril 治疗后,其存活率有所提高,但尚需进一步研究,以确定最佳治疗时机,制订最佳治疗方案。
The survival rate of patients with heart failure after conversion enzyme inhibitors captopril and enalapril has been improved, but further study is needed to determine the best timing of treatment and formulate the best treatment.